The impact of pre-donation obesity on long-term outcomes of living kidney donors remains controversial. Published guidelines offer varying recommendations regarding BMI (kg/m 2 ) thresholds for donor acceptance. We examined temporal and centerlevel variation in BMI of accepted donors across US transplant centers. Using national transplant registry data, we performed multivariate hierarchical logistic regression modeling using pairwise comparisons (overweight, BMI: 25-29.9; mildly obese, BMI:
30-34.9; very obese, BMI: ≥35; versus normal BMI: 18.5-24.9). Metrics of heterogeneity, including median odds ratio (MOR), were calculated. Among 90 013 living kidney donors, 2001-2016, proportions who were very obese decreased and proportions who were mildly obese or overweight increased. Significant center-level heterogeneity was noted in BMI of accepted donors; the MOR varied from 1.10 for overweight to 1.93 for very obese donors. At centers located in the 10 states with the highest general population obesity rates, adjusted odds of very obese donor status were 185% higher (reference: normal BMI) than in states with the lowest obesity rates. Although there is a declining trend in acceptance of very obese living kidney donors, variation across centers is significant. Furthermore, local population obesity rates may affect the decision to accept obese individuals as donors.
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clinical research, kidney transplantation, kidney transplantation: living donor, nephrology, obesity, practice of all living kidney donors were obese at the time of donation, compared with <8% in the 1970s. 5 Living donor recovery programs define criteria for donor exclusion, including BMI thresholds due to concern about associations of obesity with chronic kidney disease (CKD), 8 ESRD, and CKD risk factors (hypertension, diabetes) observed in the general population. 9 However, these thresholds are variable, given the uncertainty regarding the outcome implications among actual do- . An older study of postnephrectomy outcomes among nondonors found that obesity was associated with increased risk of proteinuria and chronic renal failure, 16 supporting the possibility that obesity and nephrectomy may pose synergistic "hits" in a pathway to renal injury and CKD.
Given the lack of consensus regarding the appropriate BMI threshold for living donor acceptance, we examined and quantified the variation in BMI among accepted donors across the United States. We also investigated trends over time, demographic and clinical characteristics of very obese living donors, and possible association of state-level obesity prevalence with acceptance of obese donors.
| METHODS

| Study design, data source, and sampling
We conducted a retrospective cohort study of living donors in the Figure 1 ). Sensitivity analysis before exclusion revealed no clinically relevant differences between the excluded and final cohorts. nation, and center volume. We allowed for clustering at the center level to allow assessment of center variation. Metrics of heterogeneity included intraclass correlation (ICC), the ratio of cluster variance (center impact) to total observed variance by BMI group. The median odds ratio (MOR) was used to estimate the average odds that patients with identical characteristics would undergo donor nephrectomy when 2 centers were drawn at random from among all centers.
| Variables
As a secondary analysis, we assessed whether obesity prevalence rates in the state of the living donor recovery center were associated with BMIs of accepted donors. We first analyzed state obesity rates in 2015. 7 We identified 10 top-ranking states according to populationlevel obesity prevalence with living kidney donor recovery centers. 
| RESULTS
| Characteristics of the study cohort
Among 90 013 US living kidney donors, mean age at donation was 41.2 ± 11.5 years and ranged from 18 to 84 years; 60.6% of donors were women. Race/ethnicity distribution was 69.9% white, 12.0% black, ) in overweight donors, P = .0001 (Table 1) . In a hierarchical model ( 
| Temporal trends in BMI
| Associations of patient-level factors with BMI group
The likelihood of very obese versus normal BMI status among accepted donors was 40% lower in donors aged younger than 30 or older than 60 years (compared with ages 30-45 years). Women (compared with men) and donors of nonwhite race/ethnicity (compared with white race) were more likely to be very obese versus normal weight.
These patterns were consistent in comparisons of mildly obese and overweight status with normal BMI status, except that accepted overweight donors were more likely to be older (Table 2) .
| Center-level variation by BMI thresholds
Center clustering explained only 0.3% and 2% of all variance for overweight and mildly obese donors, respectively (Table 3) 
| Association of donor BMI with state obesity rates
To understand whether prevalent obesity rates in the states in which centers were located may influence the acceptance of obese living donors, we performed additional secondary analysis. We noted that compared with accepted donors with normal BMI, very obese BMI status was 185% more likely (aOR 2.85; 95% CI 1.30-6.23) in states with high prevalent population obesity rates compared with states with low prevalent obesity. We also noted higher likelihood of mildly obese and overweight donor status in states with high prevalent obesity rates compared with states with low prevalent obesity rates (Table 4) . clinical and demographic donor factors, we noted that compared with era 1, the adjusted odds of very obese donor status (compared with normal BMI status) had decreased by almost 40% in era 4. However, at the same time, the odds of overweight and mildly obese status increased by 21% and 32%, respectively. These trends likely reflect increased concern about long-term risk of living donation for very obese individuals, and a relatively lower concern for overweight and mildly obese individuals, who, as recent data suggest, might also be at increased ESRD risk. 15 In addition to accepting fewer very obese donors, centers may be increasingly selective regarding such donors. Our data suggest that accepted very obese donors were less likely to be aged younger than 30 or older than 60 years. This likely reflects increased concern about lifetime ESRD risk among younger donors and about the higher comorbidity burden associated with increasing age among older donors. 22 However, despite this selectivity in age, very obese donors were more likely to be biologically related to the recipient, a group
| DISCUSSION
shown to constitute almost all donors who develop ESRD among predominantly white donors. 3, 23 In addition, very obese status was more likely in black donors, a racial group that already has a high baseline risk of ESRD 19 in the general population and among donors. (ICC = 0.32) of the variance in the model was now due to center effect.
These findings illustrate that although use of very obese donors has declined, the BMI acceptance thresholds for centers vary widely, especially in the last era of our analysis. This point can be further illustrated by the observation that in era 1, proportions of donors with very obese BMI status at 46 procuring centers were above the national average; this number had increased to 96 centers by era 4 (2012-2016; Table S1 ). This wide variation in later eras is likely driven by the lack of strong long-term data on long-term risk among very obese donors, or perhaps it reflects the local available living donor pool.
As the worldwide obesity epidemic continues, it will be reflected in the medical fitness of the overall living donor pool. A survey of 3 US transplant centers previously showed that center thresholds for various clinical characteristics have evolved over time and may reflect changing clinical and demographic characteristics of the population,
suggesting that local population characteristics may affect decisions regarding donor candidacy. 5 We noted that very obese donor status was 185% more likely in states with high obesity rates compared with states with lowest obesity rates. Whether these findings reflect the changing population demographics or a "lowering of the bar" by transplant centers in areas of high obesity prevalence cannot be established with the current data and warrants future study.
Despite the increased risk of ESRD among obese living donors, it is important to note that the absolute risk remains small. 15 Furthermore, it remains unclear whether the elevated risk of ESRD among overweight and obese living donors is attributable to the nephrectomy itself, or to the increased likelihood of developing diabetes or hypertension, both of which are strongly associated with obesity and ESRD. 21, 24 Preliminary data presented at the American Transplant Congress 2017 describing a linkage of living donor data to pharmaceutical claims data showed increased use of both insulin and noninsulin pharmacological agents among overweight and obese donors, compared with donors with normal BMI. 25 This would suggest that, like the rest of the population, obese and overweight donors remain at risk for development of diabetes after donation. Because in a large proportion of living donors who develop ESRD, the condition is attributed to diabetes or hypertension, the significance of these findings should be further investigated, and closer scrutiny of overweight and obese living donors is necessary.
Despite the strengths and findings of our study, as with any retrospective analysis, it has several limitations. First, our study included 
DISCLOSURE
The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.
